🇺🇸 FDA
Patent

US 8207361

Tigecycline crystalline forms and processes for preparation thereof

granted A61PA61P31/00A61P31/04

Quick answer

US patent 8207361 (Tigecycline crystalline forms and processes for preparation thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P31/00, A61P31/04